A record of what Neeraj Gaurh said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on the pharma sector, anticipating a turnaround in FY26 driven by a stable currency, improved FPI flows, higher government capex, and lower income tax benefits. This sector is favored over IT, with high-frequency economic indicators expected to improve from May/June 2025.”
Nifty PharmaBullishCalled 23 Mar 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Neeraj Gaurh’s full track record